Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)
Clinical trial NCT02176486 · TERMINATED
Trial details
- NCT number
- NCT02176486
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-09
- Primary completion
- 2017-03-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.